News for Inuvo, Inc. (INUV)

Shares of Precision BioSciences, Inc. DTIL rose sharply in today's pre-market trading. Precision BioSciences reported clearance of investigational new drug app...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Revenue: $26.2 million in Q4 2024, a 26% increase year-over-year.Annual Revenue: Approximately $84 million for the fiscal year 2024, a 13.4% increase.Gross Pro

Feb 27, 2025 / 09:15PM GMTOperator Good day, ladies and gentlemen, and welcome to the Inuvo, Inc. Fourth-Quarter 2024 Conference Call. At this time, all lines a

Inuvo, Inc (NYSE:INUV) Q4 2024 Earnings Conference Call February 27, 2025 4:15 PM ETCompany ParticipantsNatalya Rudman - Crescendo CommunicationsRichard...

Revenue: Achieved a record $26.2 million in Q4 2024, surpassing the estimated $24.80 million and marking a 26% year-over-year growth.Net Income: Reported a net

Inuvo Reports Unaudited Preliminary Fourth Quarter 2024 Record  Revenue of $26 Million, Achieving 26% Year-Over-Year Growth

**media[509411]**

PR NewswireNEW YORK, Nov. 20, 2024 NEW YORK, Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm,

Operator: Good day, ladies and gentlemen, and welcome to the Inuvo, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all lines are in a listen-only-mode.

Revenue: $22.4 million for Q3 2024, down 9% year over year, but up 23% sequentially.Gross Profit: $19.8 million for Q3 2024, with a gross margin of 88.4%.Opera

Nov 08, 2024 / 01:30PM GMTOperator Good day. Ladies and gentlemen and welcome to the Inuvo, Inc third Quarter 2024 earnings conference call. (Operator Instructi

Inuvo, Inc. (NYSE:INUV) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ETCompany ParticipantsNatalya Rudman – Crescendo CommunicationsRichard...

Revenue: Reported $22.4 million for Q3 2024, falling short of the analyst estimate of $22.83 million and down 9% year-over-year.Net Loss: Recorded a net loss o

**media[460275]**

**media[453209]**

Loading... Loading... Shares of Mainz Biomed N.V. MYNZ rose sharply in today's pre-market trading after the company announced submission for the FDA Breakthrou...

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a...

Read Head to Head Review: theglobe.com (OTCMKTS:TGLO) & Inuvo (NYSE:INUV) at ETF Daily News